Artificial Muscle Linear Actuator Linear Actuators heading
 

AMI Electronics- Management

 
DELETE this Page
 
 
Board of Directors

Dan Eilers
 
Dan Eilers is a General Partner of Vanguard Ventures, one of the investors in Artificial Muscle, Inc. Dan invests in software, hardware, storage, and other technology companies at Vanguard Ventures. He brings 20 years of technology and venture capital experience to his role, including serving as the President and CEO of three companies, and the founding managing partner of Apple Computer's venture capital fund.
 
Vanguard Ventures
www.vanguardventures.com

Vanguard Ventures is a leading early stage venture capital firm that helps entrepreneurs build pioneering technology and life science companies. Each Vanguard partner brings hands-on entrepreneurial experience to the firm, as well as executive and venture capital background Over the last 24 years, Vanguard Ventures has invested in over 120 companies, 30 of which have had notable success, including public companies such as Advanced Fibre Communications, Cobalt Networks, Ciena, Endotherapeutics, Network Appliance, Digital Island and Zip Realty. With each of these companies, Vanguard invested in the first round of financing.

Patrick Ennis

Patrick Ennis is a Managing Director with ARCH Venture Partners concentrating in the areas of semiconductors, materials science, communications and imaging. Patrick has 20 years of experience in the technology world as a scientist, businessman and venture capitalist. He currently serves on the boards of Artificial Muscle, Impinj, Univa, Djinnisys, Syncronex, Kotura, Innovalight and the SIRTI Research Foundation. He is a founding member of the steering committee for the Washington Nanotechnology Initiative. His previous experience includes senior positions with Lucent Technologies, AT&T, and Bell Labs.

ARCH Venture Partners
www.archventure.com

ARCH Venture Partners has been investing in seed and early-stage technology companies for more than 18 years and has special expertise in building technology companies with leading scientists and researchers from Universities and National Laboratories. ARCH manages over $1B in capital, and operates nationally with offices in Seattle, Austin, Chicago, New York, and Albuquerque.

J. Peter Marcotullio

Peter Marcotullio is the Director, Business Development of the Engineering and Systems Division of SRI International. At SRI he directs market research and analysis; intellectual property management; commercialization and business strategy development; new venture creation; marketing; project management; financial analysis; and mergers and acquisitions activity. His prior management experience includes Thermo Electron's Ventures Group and Primex Technologies. Peter has three patents with several pending and has lead the creation of six SRI companies including Artificial Muscle, Inc.

SRI International
www.sri.com

SRI International is an independent, nonprofit research institute conducting contract research and development for government agencies, commercial businesses, foundations, and other organizations. SRI also brings its innovations to the marketplace by licensing its technologies and creating new ventures. SRI International is headquartered in Menlo Park, California.

Steve E. Parry

Steve Parry is a member of NGEN Partners, LLC, an investor in Artificial Muscle, Inc. A professional geologist, Mr. Parry worked in the minerals industry for over 25 years in a series of North American and international roles structuring and managing business ventures. He held positions of General Manager and VP of Business Development for the exploration subsidiary of BHP Billiton, the world's largest mining company. Among other awards Steve received the Canada 125 medal for work as Founder and Chairman of Save Our North.

NGEN Partners, LLC:
www.ngenpartners.com

NGEN Partners, LLC provides catalytic, second-stage funding to emerging businesses within materials science and enabling technologies sectors. Areas in which NGEN specializes include (1) Polymers and organics including molecular recognition, gene chips, and active organic coatings; (2) Energy and environmental technologies including catalyst and sensor development; (3) Displays and electronic technologies including electrical, optical, magnetic, mechanical, luminescent materials, and dielectrics; and (4) Infrastructure and telecommunications including photonics, simulation technologies, high throughput experimentation, informatics, processing and manufacturing systems.

Charlie Duncheon

Charlie Duncheon started at AMI as VP of Marketing and Sales and is currently serving as interim CEO.  Prior to AMI Mr. Duncheon was Executive VP of Marketing and Sales at Adept Technology, Inc., a leading industrial robotics manufacturer where he joined at inception.  Prior to Adept he had several management roles including Monsanto Corporate Engineering.  Charlie served as president of the Robotics Industries Association and served on the RIA board for ten years.